Display options
Cite
Del Mistro A, Salamanca HF, Trevisan R, et al. Human papillomavirus typing of invasive cervical cancers in Italy. Infect Agent Cancer. 2006;1:9doi: 10.1186/1750-9378-1-9.
Del Mistro, A., Salamanca, H. F., Trevisan, R., Bertorelle, R., Parenti, A., Bonoldi, E., Zambon, P., & Minucci, D. (2006). Human papillomavirus typing of invasive cervical cancers in Italy. Infectious agents and cancer, 19. https://doi.org/10.1186/1750-9378-1-9
Del Mistro, Annarosa, et al. "Human papillomavirus typing of invasive cervical cancers in Italy." Infectious agents and cancer vol. 1 (2006): 9. doi: https://doi.org/10.1186/1750-9378-1-9
Del Mistro A, Salamanca HF, Trevisan R, Bertorelle R, Parenti A, Bonoldi E, Zambon P, Minucci D. Human papillomavirus typing of invasive cervical cancers in Italy. Infect Agent Cancer. 2006 Dec 27;1:9. doi: 10.1186/1750-9378-1-9. PMID: 17192187; PMCID: PMC1769356.
Copy Download .nbib Format: NLM
Share it on

Infect Agent Cancer. 2006 Dec 27;1:9. doi: 10.1186/1750-9378-1-9.

Human papillomavirus typing of invasive cervical cancers in Italy.

Infectious agents and cancer

Annarosa Del Mistro, Helena Frayle Salamanca, Rossana Trevisan, Roberta Bertorelle, Anna Parenti, Emanuela Bonoldi, Paola Zambon, Daria Minucci

Affiliations

  1. Immunologia e Diagnostica Molecolare Oncologica, Istituto Oncologico Veneto, Padova, Italy. [email protected]

PMID: 17192187 PMCID: PMC1769356 DOI: 10.1186/1750-9378-1-9

Abstract

BACKGROUND: Human papilloma viruses (HPV) are the necessary cause of invasive cervical cancer (ICC). Of the many different types identified so far, only a few of them account for the great majority of cases worldwide, with geographical differences in their distribution. Data on the local distribution are now of interest in view of the soon-to-come introduction of HPV type-specific prophylactic vaccines.

RESULTS: We have investigated HPV type distribution in samples of 48 ICC cases occurred in women living in North-East Italy in the years 1997-1999. Cases were extracted from the Venetian Tumour Registry files, as incident cases whose specimens had been processed in two Pathology Departments. Search and typing were performed by polymerase chain reaction (PCR) using GP5+/GP6+ primers, followed by direct sequencing or reverse dot blot. Three cases were PCR negative using the housekeeping primers and hence excluded. One case was negative by all HPV tests used. HPV 16 was present in 32 (72.7%) cases, as single infection in 28, in mixed infection in 4. Of the 44 positive cases, HPV 16 and HPV 18 accounted for 33 (75%), as single or mixed infections. The other high risk HPV types accounted for 11 (25%) of the remaining infections. Of the 32 HPV 16 positive cases, sequencing of the E6 gene could be performed in 25; the prototype isolate was identified in 7, and the variant T350G in 18; in 4 cases one or more additional mutations were present.

CONCLUSIONS: Our results suggest that HPV 16 has a very high prevalence among women with invasive cervical cancer in Italy; therefore, the use of a prophylactic vaccine for HPV types 16 and 18 could prevent up to 75% of invasive cervical cancers in Italy.

References

  1. J Low Genit Tract Dis. 2001 Jan;5(1):12-20 - PubMed
  2. Int J Cancer. 2005 Nov 1;117(2):177-81 - PubMed
  3. J Clin Virol. 2005 Mar;32 Suppl 1:S43-51 - PubMed
  4. J Clin Microbiol. 2004 Aug;42(8):3758-65 - PubMed
  5. J Gen Virol. 1995 Apr;76 ( Pt 4):1057-62 - PubMed
  6. Br J Cancer. 2003 Jul 7;89(1):101-5 - PubMed
  7. Eur J Cancer Prev. 2005 Oct;14(5):467-71 - PubMed
  8. J Med Virol. 2004 Sep;74(1):117-26 - PubMed
  9. Int J Gynecol Cancer. 2006 May-Jun;16(3):1017-24 - PubMed
  10. Pathologica. 2000 Dec;92(6):516-23 - PubMed
  11. Cancer Res. 1998 Feb 15;58(4):829-33 - PubMed
  12. Pediatrics. 2000 Oct;106(4):E57 - PubMed
  13. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):820-2 - PubMed
  14. J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9 - PubMed

Publication Types